SARS-CoV-2 Omicron Variant, Lineage BA.1, Is Associated with Lower Viral Load in Nasopharyngeal Samples Compared to Delta Variant

被引:36
|
作者
Sentis, Celia [1 ,2 ]
Billaud, Genevieve [1 ]
Bal, Antonin [1 ,2 ,3 ]
Frobert, Emilie [1 ,2 ]
Bouscambert, Maude [1 ]
Destras, Gregory [1 ,2 ,3 ]
Josset, Laurence [1 ,2 ,3 ]
Lina, Bruno [1 ,2 ]
Morfin, Florence [1 ,2 ]
Gaymard, Alexandre [1 ,2 ]
机构
[1] Hosp Civils Lyon, Inst Agents Infectieux, Ctr Natl Reference Virus Infect Resp, Lab Associe,Lab Virol, F-69004 Lyon, France
[2] Univ Claude Bernard Lyon 1, Univ Lyon, CNRS,Team VirPath,ENS Lyon, UMR 5308,INSERM,U1111,CIRI,Ctr Int Rech Infectiol, F-69007 Lyon, France
[3] Hosp Civils Lyon, Inst Agents Infectieux, GenEPII Platform, F-69004 Lyon, France
来源
VIRUSES-BASEL | 2022年 / 14卷 / 05期
关键词
SARS-CoV-2; COVID-19; viral load; Delta variant; Omicron variant;
D O I
10.3390/v14050919
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Objectives: High viral load in upper respiratory tract specimens observed for Delta cases might contribute to its increased infectivity compared to the other variant. However, it is not yet documented if the Omicron variant's enhanced infectivity is also related to a higher viral load. Our aim was to determine if the Omicron variant's spread is also related to higher viral loads compared to the Delta variant. Methods: Nasopharyngeal swabs, 129 (Omicron) and 85 (Delta), from Health Care Workers were collected during December 2021 at the University Hospital of Lyon, France. Cycle threshold (Ct) for the RdRp target of cobas (R) 6800 SARS-CoV-2 assay was used as a proxy to evaluate SARS-CoV-2 viral load. Variant identification was performed using a screening panel and confirmed by whole genome sequencing. Results: Herein, we showed that the RT-PCR Ct values in Health Care Workers sampled within 5 days after symptom onset were significantly higher for Omicron cases than Delta cases (21.7 for Delta variant and 23.8 for Omicron variant, p = 0.008). This difference was also observed regarding patient with complete vaccination. Conclusions: This result supports the studies showing that the increased transmissibility of Omicron is related to other mechanisms than higher virus excretion.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Infection, pathology and interferon treatment of the SARS-CoV-2 Omicron BA.1 variant in juvenile, adult and aged Syrian hamsters
    Lunzhi Yuan
    Huachen Zhu
    Peiwen Chen
    Ming Zhou
    Jian Ma
    Xuan Liu
    Kun Wu
    Rirong Chen
    Qiwei Liu
    Huan Yu
    Lifeng Li
    Jia Wang
    Yali Zhang
    Shengxiang Ge
    Quan Yuan
    Qiyi Tang
    Tong Cheng
    Yi Guan
    Ningshao Xia
    [J]. Cellular & Molecular Immunology, 2022, 19 : 1392 - 1399
  • [42] Rapid assembly of SARS-CoV-2 genomes reveals attenuation of the Omicron BA.1 variant through NSP6
    Taha Y. Taha
    Irene P. Chen
    Jennifer M. Hayashi
    Takako Tabata
    Keith Walcott
    Gabriella R. Kimmerly
    Abdullah M. Syed
    Alison Ciling
    Rahul K. Suryawanshi
    Hannah S. Martin
    Bryan H. Bach
    Chia-Lin Tsou
    Mauricio Montano
    Mir M. Khalid
    Bharath K. Sreekumar
    G. Renuka Kumar
    Stacia Wyman
    Jennifer A. Doudna
    Melanie Ott
    [J]. Nature Communications, 14 (1)
  • [43] Infection, pathology and interferon treatment of the SARS-CoV-2 Omicron BA.1 variant in juvenile, adult and aged Syrian hamsters
    Yuan, Lunzhi
    Zhu, Huachen
    Chen, Peiwen
    Zhou, Ming
    Ma, Jian
    Liu, Xuan
    Wu, Kun
    Chen, Rirong
    Liu, Qiwei
    Yu, Huan
    Li, Lifeng
    Wang, Jia
    Zhang, Yali
    Ge, Shengxiang
    Yuan, Quan
    Tang, Qiyi
    Cheng, Tong
    Guan, Yi
    Xia, Ningshao
    [J]. CELLULAR & MOLECULAR IMMUNOLOGY, 2022, 19 (12) : 1392 - 1399
  • [44] Clinical severity of SARS-CoV-2 Omicron BA.4 and BA.5 lineages compared to BA.1 and Delta in South Africa
    Nicole Wolter
    Waasila Jassat
    Sibongile Walaza
    Richard Welch
    Harry Moultrie
    Michelle J. Groome
    Daniel Gyamfi Amoako
    Josie Everatt
    Jinal N. Bhiman
    Cathrine Scheepers
    Naume Tebeila
    Nicola Chiwandire
    Mignon du Plessis
    Nevashan Govender
    Arshad Ismail
    Allison Glass
    Koleka Mlisana
    Wendy Stevens
    Florette K. Treurnicht
    Kathleen Subramoney
    Zinhle Makatini
    Nei-yuan Hsiao
    Raveen Parboosing
    Jeannette Wadula
    Hannah Hussey
    Mary-Ann Davies
    Andrew Boulle
    Anne von Gottberg
    Cheryl Cohen
    [J]. Nature Communications, 13
  • [45] Introduction and Rapid Spread of SARS-CoV-2 Omicron Variant and Dynamics of BA.1 and BA.1.1 Sublineages, Finland, December 2021
    Vauhkonen, Hanna
    Nguyen, Phuoc Truong
    Kant, Ravi
    Plyusnin, Ilja
    Erdin, Mert
    Kurkela, Satu
    Liimatainen, Hanna
    Ikonen, Niina
    Blomqvist, Soile
    Liitsola, Kirsi
    Lindh, Erika
    Helve, Otto
    Jarva, Hanna
    Loginov, Raisa
    Palva, Aino
    Hannunen, Tiina
    Hannula, Sari
    Parry, Mikko
    Kauppi, Paula
    Vaheri, Antti
    Sironen, Tarja
    Lappalainen, Maija
    Savolainen-Kopra, Carita
    Smura, Teemu
    Vapalahti, Olli
    [J]. EMERGING INFECTIOUS DISEASES, 2022, 28 (06) : 1229 - 1232
  • [46] Clinical severity of SARS-CoV-2 Omicron BA.4 and BA.5 lineages compared to BA.1 and Delta in South Africa
    Wolter, Nicole
    Jassat, Waasila
    Walaza, Sibongile
    Welch, Richard
    Moultrie, Harry
    Groome, Michelle J.
    Amoako, Daniel Gyamfi
    Everatt, Josie
    Bhiman, Jinal N.
    Scheepers, Cathrine
    Tebeila, Naume
    Chiwandire, Nicola
    du Plessis, Mignon
    Govender, Nevashan
    Ismail, Arshad
    Glass, Allison
    Mlisana, Koleka
    Stevens, Wendy
    Treurnicht, Florette K.
    Subramoney, Kathleen
    Makatini, Zinhle
    Hsiao, Nei-yuan
    Parboosing, Raveen
    Wadula, Jeannette
    Hussey, Hannah
    Davies, Mary-Ann
    Boulle, Andrew
    von Gottberg, Anne
    Cohen, Cheryl
    [J]. NATURE COMMUNICATIONS, 2022, 13 (01)
  • [47] Clinical factors associated with viral shedding time of SARS-CoV-2 Omicron variant in Japan
    Akata, Kentaro
    Yamasaki, Kei
    Kohrogi, Rikuto
    Kawakami, Yoko
    Furuya, Yorikazu
    Eto, Kohichiro
    Honda, Masahisa
    Suzuki, Katsunori
    Yatera, Kazuhiro
    [J]. JOURNAL OF INFECTION AND CHEMOTHERAPY, 2024, 30 (02) : 172 - 175
  • [48] Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant
    Saito, Akatsuki
    Tamura, Tomokazu
    Zahradnik, Jiri
    Deguchi, Sayaka
    Tabata, Koshiro
    Anraku, Yuki
    Kimura, Izumi
    Ito, Jumpei
    Yamasoba, Daichi
    Nasser, Hesham
    Toyoda, Mako
    Nagata, Kayoko
    Uriu, Keiya
    Kosugi, Yusuke
    Fujita, Shigeru
    Shofa, Maya
    Begum, Mst Monira
    Shimizu, Ryo
    Oda, Yoshitaka
    Suzuki, Rigel
    Ito, Hayato
    Nao, Naganori
    Wang, Lei
    Tsuda, Masumi
    Yoshimatsu, Kumiko
    Kuramochi, Jin
    Kita, Shunsuke
    Sasaki-Tabata, Kaori
    Fukuhara, Hideo
    Maenaka, Katsumi
    Yamamoto, Yuki
    Nagamoto, Tetsuharu
    Asakura, Hiroyuki
    Nagashima, Mami
    Sadamasu, Kenji
    Yoshimura, Kazuhisa
    Ueno, Takamasa
    Schreiber, Gideon
    Takaori-Kondo, Akifumi
    Shirakawa, Kotaro
    Sawa, Hirofumi
    Irie, Takashi
    Hashiguchi, Takao
    Takayama, Kazuo
    Matsuno, Keita
    Tanaka, Shinya
    Ikeda, Terumasa
    Fukuhara, Takasuke
    Sato, Kei
    [J]. CELL HOST & MICROBE, 2022, 30 (09) : 1540 - +
  • [49] Clinical outcomes associated with SARS-CoV-2 Omicron (B.1.1.529) variant and BA.1/BA.1.1 or BA.2 subvariant infection in Southern California
    Joseph A. Lewnard
    Vennis X. Hong
    Manish M. Patel
    Rebecca Kahn
    Marc Lipsitch
    Sara Y. Tartof
    [J]. Nature Medicine, 2022, 28 : 1933 - 1943
  • [50] SARS-CoV-2 Omicron Replacement of Delta as Predominant Variant, Puerto Rico
    Santiago, Gilberto A.
    Volkman, Hannah R.
    Flores, Betzabel
    Gonzalez, Glenda L.
    Charriez, Keyla N.
    Huertas, Limari Cora
    Van Belleghem, Steven M.
    Rivera-Amill, Vanessa
    Major, Chelsea
    Colon, Candimar
    Tosado, Rafael
    Adams, Laura E.
    Marzan, Melissa
    Hernandez, Lorena
    Cardona, Iris
    O'Neill, Eduardo
    Paz-Bailey, Gabriela
    Papa, Riccardo
    Munoz-Jordan, Jorge L.
    [J]. EMERGING INFECTIOUS DISEASES, 2023, 29 (04) : 855 - 857